Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Unapproved Drug Initiative Nixed, But Without Agency Buy-In Demise May Be Short-Lived
Nov 24 2020
•
By
Sarah Karlin-Smith
HHS halts FDA program that encourages marketing approval of old drugs • Source: Shutterstock
More from US FDA
More from Agency Leadership